| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman, President And CEO
4 companies
Heffernan Michael Thomas is a Director at COLLEGIUM PHARMACEUTICAL, INC with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 15 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | Director | Buy | 2,500 | $10.00 | $25,000.00 | +64.9% | |
| Apr 15, 2019 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $15.09 | $377,365.68 | -5.8% | |
| Mar 15, 2019 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $17.17 | $429,250.00 | -9.9% | |
| Feb 15, 2019 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $14.81 | $370,223.80 | -4.7% | |
| Jan 15, 2019 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $15.56 | $389,000.00 | -8.0% | |
| Dec 17, 2018 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $18.18 | $454,490.85 | -3.8% | |
| Nov 15, 2018 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $16.60 | $415,122.00 | -3.6% | |
| Oct 15, 2018 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 25,000 | $16.53 | $413,250.00 | -6.5% | |
| Jun 12, 2018 | COLL Collegium Pharmaceutical, Inc | Chairman, President And CEO | Sell | 150,000 | $25.27 | $3,790,938.86 | -15.3% | |
| May 10, 2018 | COLL Collegium Pharmaceutical, Inc | Chairman, President And CEO | Sell | 7,100 | $26.21 | $186,100.00 | -0.7% |